RaySearch Laboratories AB has launched the latest release of its widely adopted treatment planning system. RayStation 10B adds support for brachytherapy planning and a new GPU Monte Carlo algorithm, which typically cuts final dose computation times to less than five seconds.

December 29, 2020 — RaySearch Laboratories AB has launched the latest release of its widely adopted treatment planning system. RayStation 10B adds support for brachytherapy planning and a new GPU Monte Carlo algorithm, which typically cuts final dose computation times to less than five seconds.

In line with the company’s aim of integrating with as many treatment delivery systems as possible, the new release includes support for high-dose-rate (HDR) brachytherapy planning. RayStation 10B features automatic channel reconstruction in combination with powerful dwell-time optimization, enabling faster and more consistent creation of high-quality brachytherapy plans. The efficiency and possibilities of brachytherapy planning are further enhanced by tools for working with multiple image sets, image deformation and dose summation. 

HDR brachytherapy is a radiation therapy technique in which a small radioactive source is placed at different positions inside the patient to obtain an advantageous dose distribution. High doses can be delivered to tumors while sparing organs at risk. The technique is used, for example, to treat gynecological, prostate, breast, head-and-neck and skin cancers.

Another notable addition in RayStation 10B is the multi-GPU Monte Carlo dose engine for proton planning. With typical final dose computation times of less than five seconds, the GPU Monte Carlo algorithm is expected to revolutionize planning workflows at proton clinics. The physics algorithms of the GPU proton Monte Carlo dose engine are identical to those in the now well-established RayStation CPU proton Monte Carlo dose engine, and dosimetric results are equally strong.

Machine-learning capabilities were introduced in RayStation 8B and are being continuously improved with each successive release. In RayStation 10B, machine learning applications further increase efficiency and improve consistency for photon and robust proton planning, and deep-learning organ segmentation. 

The robust optimization framework has been extended to take intra- and inter-fractional motion into account, with consideration for motion during the delivery of single fractions and changes over the entire treatment course. This framework supports improved plan quality, for example in cases with organ motion. 10B also introduces machine parameter improvements to utilize the full potential of the most common linacs. As a result, it is now possible to create treatment plans with more conformal dose distribution and lower dose to organs at risk.

Other enhancements include closer integration with the oncology information system RayCare. When running RayStation in a RayCare environment, the planning task list is now accessible in RayStation for improved workflow management.

Johan Löf, CEO of RaySearch, said: “Each release of RayStation takes clinical workflows to the next level. Brachytherapy is a highly accurate technique, and the capabilities of our advanced software will bring a new dimension to the treatment of several cancer types.”

For more information: www.raysearchlabs.com

Related Content

News | Molecular Imaging

January 28, 2022 — TeamBest Global Companies (TBG) and Best Cyclotron Systems, Inc. (BCS) announce the shipment of the ...

Time January 28, 2022
arrow
News | Radiation Oncology

January 27, 2022 — New guidelines for treating cancers that have spread to the brain are poised to improve care for ...

Time January 27, 2022
arrow
News | Nuclear Imaging

January 26, 2022 — On January 24, the Emergency Response Team (ERT) of Nuclear Medicine Europe (NMEu) communicated that ...

Time January 26, 2022
arrow
News | Prostate Cancer

January 19, 2022 — For the first time, researchers led by a team from the UCLA Jonsson Comprehensive Cancer Center used ...

Time January 19, 2022
arrow
News | Lung Imaging

January 17, 2022 — A recent, substantial decline in lung cancer deaths is associated with earlier diagnosis of lung ...

Time January 17, 2022
arrow
News | Radiation Therapy

January 13, 2022 — A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides guidance ...

Time January 13, 2022
arrow
News | Radiation Therapy

January 10, 2022 — Nanobiotix, a late-stage clinical biotechnology company pioneering physics-based approaches to expand ...

Time January 10, 2022
arrow
News | Radiation Oncology

January 7, 2022 — Varian and parent company Siemens Healthineers have been recognized in the annual IMV ServiceTrak ...

Time January 07, 2022
arrow
News | Radiation Oncology

January 7, 2022 — A Case Western Reserve University-led team of scientists has used Artificial Intelligence (AI) to ...

Time January 07, 2022
arrow
News | Proton Therapy

January 3, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and ...

Time January 03, 2022
arrow
Subscribe Now